SRTAW (SRTAW) Stock Price & Analysis
SRTAW (SRTAW) fell 88.68% to USD 0 as of June 10, 2026 at 13:40 UTC, according to Nexqual real-time market data.
SRTAW last closed at USD 0.01; the session ranged USD 0–0 on volume of 638,916 shares. Market capitalization is —, with a 52-week range of USD 0–0 (NCM). Source: Nexqual, June 10, 2026 at 13:40 UTC.
Key Statistics (as of June 10, 2026 at 13:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▼ 88.68% (down) |
| Previous Close | USD 0.01 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 638,916 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (SRTAW)
Nexqual's technical model rates SRTAW "BUY" based on 5 bullish and 1 bearish signals across 51 daily candles, as of June 10, 2026 at 13:40 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0.03) |
| MACD | 0 (negative) |
Analyst Ratings (SRTAW)
Wall Street analysts rate SRTAW "None", per Nexqual as of June 10, 2026 at 13:40 UTC.
| Consensus Rating | None |
|---|
Earnings (SRTAW)
| Revenue Estimate | $66.16M |
|---|
Source: Nexqual, June 10, 2026 at 13:40 UTC.
Financials & Fundamentals (SRTAW)
| Total Revenue | $228.58M |
|---|---|
| Revenue Growth (YoY) | +24.10% |
| Gross Margin | +21.08% |
| Operating Margin | -2.52% |
| Profit Margin | +20.56% |
| ROE | -6.35% |
| Debt / Equity | 1.56 |
| Current Ratio | 5.93 |
| Total Cash | $58.79M |
| Total Debt | $4.47M |
| Free Cash Flow | $-24.54M |
Source: Nexqual, June 10, 2026 at 13:40 UTC.
Financial Health Score (SRTAW)
Nexqual rates SRTAW's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 13:40 UTC.
| Growth | Critical — Revenue -21% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 21%, operating -3% |
| Balance Sheet | Strong — $59M cash vs $4M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$25M, burning cash |
| Efficiency | Critical — ROE -6%, ROA -1.9% |
Ownership (SRTAW)
| Float | 61.70M |
|---|
Source: Nexqual, June 10, 2026 at 13:40 UTC.
Leadership (SRTAW)
SRTAW is led by Melissa M. Tomkiel (age 44), Co- CEO, General Counsel, Corporate Secretary & Director, per Nexqual as of June 10, 2026 at 13:40 UTC.
| Co- CEO, General Counsel, Corporate Secretary & Director | Melissa M. Tomkiel (age 44) |
|---|---|
| Co-CEO, CFO & Director | William A. Heyburn (age 36) |
| CFO of Clinical Services & VP of Finance and Investor Relations | Mathew Schneider C.F.A. |
Major Backers & Investors (SRTAW)
Notable institutional backers of SRTAW include LMR Partners LLP, Virtu Financial LLC, Wolverine Asset Management, LLC, according to Nexqual as of June 10, 2026 at 13:40 UTC.
Active Investors
| Investor | Stake |
|---|---|
| LMR Partners LLP | 13.28% |
| Virtu Financial LLC | 1.3% |
| Wolverine Asset Management, LLC | 1.03% |
| Saba Capital Management, L.P. | 0.2% |
Source: Nexqual, June 10, 2026 at 13:40 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JOBY-WT | Joby Aviation, Inc. WT | USD 0.65 | ▼ 2.01% |
| ACHR-WT | Archer Aviation Inc. WT | USD 0.12 | ▲ 1.69% |
| FFAIW | Faraday Future Intelligent Electric Inc. | USD 0.01 | ▼ 20.13% |
| SRTA | Strata Critical Medical, Inc. | USD 5.59 | ▼ 4.77% |
| EVGOW | EVgo Inc. Warrants | USD 0.01 | ▼ 15.29% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:40 UTC. This page is informational and not investment advice.